INITIAL SCREENING FOR CARCINOGENICITY OF COMMONLY USED DRUGS

[1] LACK OF EVIDENCE FOR CANCER DUE TO USE OF METRONIDAZOLE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (10) : 519 - 522

[2] FRIEDMAN GD, 1980, NEW ENGL J MED, V302, P519

[3] SCREENING CRITERIA FOR DRUG MONITORING - KAISER-PERMANENTE DRUG REACTION MONITORING SYSTEM [J]. JOURNAL OF CHRONIC DISEASES, 1972, 25 (01): : 11 - &

[4] HOOVER R, 1975, PERSONS HIGH RISK CA, P185

[5] BREAST-CANCER AND SPIRONOLACTONE [J]. LANCET, 1975, 2 (7930) : 368 - 369

[6] Kelsey J L, 1979, Epidemiol Rev, V1, P74

[7] BREAST-CANCER ASSOCIATED WITH ADMINISTRATION OF SPIRONOLACTONE [J]. LANCET, 1975, 1 (7922) : 1428 - 1429

[8] INCIDENCE OF CERVICAL-CANCER AND DURATION OF ORAL-CONTRACEPTIVE USE [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 106 (06) : 462 - 469

[9] ROTHMAN KJ, 1975, PERSONS HIGH RISK CA, P139

[10] SMOKING AND DRUG CONSUMPTION IN WHITE, BLACK, AND ORIENTAL MEN AND WOMEN [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1974, 64 (05) : 466 - 473

[1] LACK OF EVIDENCE FOR CANCER DUE TO USE OF METRONIDAZOLE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (10) : 519 - 522

[2] FRIEDMAN GD, 1980, NEW ENGL J MED, V302, P519

[3] SCREENING CRITERIA FOR DRUG MONITORING - KAISER-PERMANENTE DRUG REACTION MONITORING SYSTEM [J]. JOURNAL OF CHRONIC DISEASES, 1972, 25 (01): : 11 - &

[4] HOOVER R, 1975, PERSONS HIGH RISK CA, P185

[5] BREAST-CANCER AND SPIRONOLACTONE [J]. LANCET, 1975, 2 (7930) : 368 - 369

[6] Kelsey J L, 1979, Epidemiol Rev, V1, P74

[7] BREAST-CANCER ASSOCIATED WITH ADMINISTRATION OF SPIRONOLACTONE [J]. LANCET, 1975, 1 (7922) : 1428 - 1429

[8] INCIDENCE OF CERVICAL-CANCER AND DURATION OF ORAL-CONTRACEPTIVE USE [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 106 (06) : 462 - 469

[9] ROTHMAN KJ, 1975, PERSONS HIGH RISK CA, P139

[10] SMOKING AND DRUG CONSUMPTION IN WHITE, BLACK, AND ORIENTAL MEN AND WOMEN [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1974, 64 (05) : 466 - 473